Tag: hepatitis
AbbVie hepatitis C drugs knock out virus at eight weeks
by on Apr.23, 2013, under Health and Fitness
By Ransdell Pierson and Bill Berkrot (Reuters) – A combination of five oral drugs being tested by AbbVie Inc cured at least 88 percent of new patients with hepatitis C after only eight weeks of treatment, without raising significant safety issues,…
View full post on Yahoo! Health News
Oklahoma warns 7,000 dental patients of HIV, hepatitis risk
by on Mar.31, 2013, under Health and Fitness
By Steve Olafson OKLAHOMA CITY (Reuters) – Health officials are notifying some 7,000 people to warn they may have been exposed to HIV and other infectious diseases at an Oklahoma dental practice where improper sterilization procedures and rusty su…
View full post on Yahoo! Health News
FDA rejects Dynavax’s adult hepatitis B vaccine on safety concerns
by on Feb.26, 2013, under Health and Fitness
(Reuters) – U.S. health regulators denied approval for Dynavax Technologies Inc's adult hepatitis B vaccine pending additional data to evaluate its safety, potentially delaying the U.S. market entry of the company's first promising product…
View full post on Yahoo! Health News
Hepatitis C tests continue after NH tech’s arrest
by on Dec.23, 2012, under Health and Fitness
CONCORD, N.H. (AP) — Hospitals across the country recommended hepatitis C testing for about 7,900 patients last summer after a traveling medical worker was accused of stealing drugs and infecting patients with tainted syringes in New Hampshire. Bu…
View full post on Yahoo! Health News
Gilead hepatitis C drug shows promise in late-stage trial
by on Nov.27, 2012, under Health and Fitness
(Reuters) – Gilead Sciences said a late-stage trial of its experimental hepatitis C treatment showed that the virus was not detected in 78 percent of patients taking the drug, 12 weeks after completing therapy. The trial, named Positron, was testi…
View full post on Yahoo! Health News
FDA approves Glaxo-Ligand platelet drug for hepatitis C patients
by on Nov.19, 2012, under Health and Fitness
(Reuters) – GlaxoSmithKline Plc said U.S. health regulators had approved its drug Promacta for the additional use of treating hepatitis C patients with a low platelet count who are unable to undergo standard hepatitis C therapy. The drug, develope…
View full post on Yahoo! Health News
Boehringer Ingelheim to start late-stage hepatitis C drug trial
by on Nov.11, 2012, under Health and Fitness
BOSTON (Reuters) – Boehringer Ingelheim said on Saturday it plans to initiate a late-stage clinical trial of its experimental hepatitis C treatment following promising results from earlier studies. The company announced final data from a mid-stage…
View full post on Yahoo! Health News
Gilead posts positive results in mid-stage Hepatitis C study
by on Nov.10, 2012, under Health and Fitness
(Reuters) – Gilead Sciences Inc on Saturday reported a 100 percent cure rate using a combination of drugs in a small number of patients with the most common and hardest to treat form of hepatitis C. Rival Abbott Laboratories Inc, meanwhile, said a…
View full post on Yahoo! Health News
Abbott hepatitis C drugs produce high cure rates in trial
by on Nov.10, 2012, under Health and Fitness
(Reuters) – A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had previously failed to benefit from standard treatment, as well as very high cure rates for newly treated pa…
View full post on Yahoo! Health News
Hepatitis hits more than 1,000 refugees in South Sudan: UNHCR
by on Nov.09, 2012, under Health and Fitness
GENEVA (Reuters) – An outbreak of hepatitis E has infected at least 1,050 Sudanese refugees in South Sudan, killing 26 and threatening to spread further among people still arriving in crowded camps, the United Nations said on Friday. About 175,000…
View full post on Yahoo! Health News
